1444 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
Metabolic Associated Fatty Liver Disease and Cardiovascular Disease
|
Jian-Gao Fan |
|
356 |
1443 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
How Nonalcoholic Fatty Liver Disease Patients Die: Heart, Liver, or Other Cancers?
|
Jeong-Ju Yoo |
|
321 |
1442 |
간경변증 |
간경변증 |
2021 |
Measurement of Hepatic Venous Pressure Gradient and Its Clinical Significance during TIPS or BRTO/PARTO: Tips and Pitfalls
|
Hitoshi Maruyama |
|
558 |
1441 |
간경변증 |
간경변증 |
2021 |
Application of Hepatic Venous Pressure Gradient for Predicting Prognosis in Liver Cirrhosis
|
Young Chang |
|
331 |
1440 |
간경변증 |
간경변증 |
2021 |
Tailored Treatment of Cirrhotic Complications According to Hepatic Venous Pressure Gradient
|
Jung Gil Park |
|
299 |
1439 |
간경변증 |
간경변증 |
2021 |
Non-Invasive Estimation of Hepatic Venous Pressure Gradient
|
Young Seo Cho |
|
315 |
1438 |
알코올 간질환 |
알코올 간질환 |
2021 |
Microbiome as a Potential Diagnostic Biomarker in Severe Alcoholic Hepatitis
|
Soon Sun Kim |
|
389 |
1437 |
알코올 간질환 |
알코올 간질환 |
2021 |
Prognosis and Outcome of Patients with Alcohol-Associated Acute-On-Chronic Liver Failure
|
Eileen L. Yoon |
|
342 |
1436 |
알코올 간질환 |
알코올 간질환 |
2021 |
Clinical, Histological, and Molecular Profiling of Different Stages of Alcohol-Related Steatohepatitis
|
Ramon Bataller |
|
304 |
1435 |
알코올 간질환 |
알코올 간질환 |
2021 |
Non-Invasive Diagnosis and Biomarkers in Alcohol-Related Liver Disease
|
Young Kul Jung |
|
286 |
1434 |
바이러스 간질환 |
B형 간염 |
2021 |
Latest Treatment Drugs for Hepatitis B and C and Treatment of Hepatitis D and E
|
Wonseok Kang |
|
281 |
1433 |
바이러스 간질환 |
B형 간염 |
2021 |
Viral Hepatitis: The Path I have Taken as a Clinician and Researcher of Viral Hepatitis
|
Kwang-Hyub Han |
|
341 |
1432 |
간종양 |
간세포암 |
2021 |
Management of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors
|
Tae Yong Kim |
|
340 |
1431 |
간경변증 |
간경변증 |
2021 |
Early TIPS for Improving Outcomes of Acute Variceal Bleeding: Who Are the Appropriate Candidates?
|
Guohong Han |
|
306 |
1430 |
간종양 |
간세포암 |
2021 |
Clinical Application of Liquid Biopsy as a Prognostic Biomarker in Hepatocellular Carcinoma
|
Soo Young Park |
|
319 |
1429 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
Novel Insights of Translational Research in Nonalcoholic Steatohepatitis and Fibrosis
|
Scott Friedman |
|
326 |
1428 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
KASL Clinical Practice Guidelines
|
Yong Kyun Cho |
|
362 |
1427 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
MAFLD vs. NAFLD: What's in the Name? Cons: Premature Proposition
|
Ajay Duseja |
|
330 |
1426 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
Which Is the More Appropriate Surrogate and Target? Liver Fibrosis and/or Inflammation
|
Vincent Wong |
|
330 |
1425 |
비알코올 지방간질환 |
비알코올 지방간질환 |
2021 |
Which Is the More Appropriate Surrogate and Target? Metabolic Factors and/or Steatosis
|
Dae Won Jun |
|
307 |